{
  "cik": 1501796,
  "cik_padded": "0001501796",
  "entityName": "Aura Biosciences, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-130401",
      "filed": "2026-03-30",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 447000.0,
        "cash": 59515000.0,
        "eps_diluted": -1.76,
        "free_cash_flow": -85189000.0,
        "net_income": -106191000.0,
        "operating_cash_flow": -84742000.0,
        "operating_income": -112791000.0,
        "stockholders_equity": 136913000.0,
        "total_assets": 169430000.0,
        "total_liabilities": 32517000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.23750118688510222,
        "roa_avg2y": -0.6034728201106461,
        "roa_period_end": -0.626754411851502,
        "roe_avg2y": -0.7351834479702856,
        "roe_period_end": -0.775609328551708
      }
    },
    {
      "accn": "0001193125-26-130401",
      "filed": "2026-03-30",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1253000.0,
        "cash": 31693000.0,
        "eps_diluted": -1.75,
        "free_cash_flow": -81058000.0,
        "net_income": -86919000.0,
        "operating_cash_flow": -79805000.0,
        "operating_income": -96116000.0,
        "stockholders_equity": 151970000.0,
        "total_assets": 182503000.0,
        "total_liabilities": 30533000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.2009146542080674,
        "roa_avg2y": -0.3972731718687868,
        "roa_period_end": -0.4762606642082596,
        "roe_avg2y": -0.4601104235372587,
        "roe_period_end": -0.5719484108705666
      }
    },
    {
      "accn": "0001193125-26-130401",
      "filed": "2026-03-30",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 709000.0,
        "cash": 41063000.0,
        "eps_diluted": -1.93,
        "free_cash_flow": -64556000.0,
        "net_income": -76408000.0,
        "operating_cash_flow": -63847000.0,
        "operating_income": -84991000.0,
        "stockholders_equity": 225848000.0,
        "total_assets": 255075000.0,
        "total_liabilities": 29227000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.12941004569444936,
        "roa_avg2y": -0.31902465501764055,
        "roa_period_end": -0.2995511124179163,
        "roe_avg2y": -0.3626121476588101,
        "roe_period_end": -0.33831603556374207
      }
    },
    {
      "accn": "0000950170-25-043943",
      "filed": "2025-03-24",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1094000.0,
        "cash": 121582000.0,
        "eps_diluted": -1.96,
        "free_cash_flow": -55695000.0,
        "net_income": -58763000.0,
        "operating_cash_flow": -54601000.0,
        "operating_income": -60295000.0,
        "stockholders_equity": 195583000.0,
        "total_assets": 223935000.0,
        "total_liabilities": 28352000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.14496147415675187,
        "roa_avg2y": -0.30608519005638535,
        "roa_period_end": -0.26241096746823855,
        "roe_avg2y": -0.33781740625125756,
        "roe_period_end": -0.30045044814733385
      }
    },
    {
      "accn": "0000950170-24-036814",
      "filed": "2024-03-27",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 2125000.0,
        "cash": 149063000.0,
        "eps_diluted": -8.95,
        "free_cash_flow": -34535000.0,
        "net_income": -35251000.0,
        "operating_cash_flow": -32410000.0,
        "operating_income": -35250000.0,
        "stockholders_equity": 152315000.0,
        "total_assets": 160030000.0,
        "total_liabilities": 7715000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.05065161015001805,
        "roa_avg2y": -0.3870886270548058,
        "roa_period_end": -0.22027744797850402,
        "roe_avg2y": -1.6169441768726205,
        "roe_period_end": -0.23143485539835212
      }
    },
    {
      "accn": "0000950170-23-008166",
      "filed": "2023-03-15",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 771000.0,
        "cash": 17393000.0,
        "free_cash_flow": -25092000.0,
        "net_income": -22206000.0,
        "operating_cash_flow": -24321000.0,
        "operating_income": -22206000.0,
        "stockholders_equity": -108713000.0,
        "total_assets": 22104000.0,
        "total_liabilities": 2741000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -1.004614549402823,
        "roe_avg2y": 0.22645434659568936
      }
    },
    {
      "accn": "0000950170-22-004425",
      "filed": "2022-03-23",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -87406000.0
      },
      "period_end": "2019-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-130401",
    "filed": "2026-03-30",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001501796.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001501796.json"
  },
  "ticker": "AURA"
}